Christopher Delorefice sells 9,366 BDX shares for $1.71M (NYSE: BDX)

Rhea-AI Filing Summary

Becton, Dickinson and Company reported an insider sale. Christopher Delorefice sold 9,366 common shares on 02/18/2026 for $1,708,885.71. The filing lists multiple issuer-side equity award vesting and exercise events dated between 11/26/2024 and 11/26/2025.

Insights

Corporate Governance Analyst

Insider sale is disclosed and appears routine, tied to equity awards.

The record shows 9,366 shares sold by Christopher Delorefice on 02/18/2026 for $1,708,885.71. The filing also lists issuer-side vesting and option-exercise events dated 11/26/2024 through 11/26/2025.

These items align with scheduled equity compensation activity; subsequent filings would show whether further selling occurs.

Securities Compliance Counsel

Form 144 provides notice for an intended sale under Rule 144; details are transactional.

The submission names the seller, the sale date 02/18/2026, number of shares 9,366, and proceeds $1,708,885.71. It also lists multiple award vesting/exercise entries from 11/26/2024 to 11/26/2025.

Trade mechanics and any resale limits are not detailed here; future SEC reports may record completed transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	11305	2079070.15	284741809	02/20/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/26/2024	Performance Stock Units	Issuer			1517	11/26/2024	Services Rendered
Common	02/20/2026	Exercise of options under a registered plan	Issuer			1940	02/20/2026	Services Rendered
Common	11/26/2024	Restricted stock vesting under a registered plan	Issuer			1708	11/26/2024	Services Rendered
Common	11/26/2025	Performance Stock Units	Issuer			3398	11/26/2025	Services Rendered
Common	11/26/2025	Restricted stock vesting under a registered plan	Issuer			2128	11/26/2025	Services Rendered
Common	09/01/2025	Restricted stock vesting under a registered plan	Issuer			614	09/01/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHRISTOPHER DELOREFICE 1 Becton Drive Franklin Lakes NJ 07417	Common	02/18/2026	9366	1708885.71

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did the BDX filing disclose about insider Christopher Delorefice?

The filing discloses a sale of 9,366 shares on 02/18/2026 for $1,708,885.71. The record also lists issuer-side equity vesting and option exercises dated between 11/26/2024 and 11/26/2025 that relate to compensation events.

How many shares did Christopher Delorefice sell according to the Form 144?

The Form 144 shows a sale of 9,366 common shares. The sale date recorded is 02/18/2026 and the proceeds shown are $1,708,885.71, with other issuer award vesting entries included in the filing.

Does the filing show these shares came from vested awards or open-market holdings?

The filing lists issuer-side events including performance stock units, restricted stock vesting, and option exercises. It enumerates vesting/exercise dates between 11/26/2024 and 11/26/2025, indicating compensation-related sources in the record.

When were the equity awards and vesting events listed in the filing dated?

The filing lists award and vesting dates of 11/26/2024, 11/26/2025, and 09/01/2025. It also records an exercise event and a sale date of 02/20/2026 in the securities schedule.

Does Form 144 confirm completion of the sale or only notice of intent?

The Form 144 entry records a sale on 02/18/2026 with proceeds of $1,708,885.71. Additional SEC filings would show any follow-up confirmations or related Form 4 disclosures if required.